Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.010
+0.042 (4.38%)
Aug 5, 2026, 12:35 PM EDT - Market open
Tiziana Life Sciences Employees
Tiziana Life Sciences had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,843,100
Market Cap
130.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10 | 1 | 11.11% |
| Dec 31, 2024 | 9 | 0 | - |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | -5 | -35.71% |
| Dec 31, 2021 | 14 | 3 | 27.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Nautilus Biotechnology | 127 |
| Seer, Inc. | 124 |
| Connect Biopharma Holdings | 64 |
| PepGen | 59 |
| Vivani Medical | 42 |
| Genelux | 26 |
| TuHURA Biosciences | 22 |
TLSA News
- 1 day ago - Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer - GlobeNewsWire
- 5 days ago - Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab - GlobeNewsWire
- 14 days ago - Tiziana Life Sciences chairman Gabriele Cerrone purchases 42,357 shares at 99c - TheFly
- 14 days ago - Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman - GlobeNewsWire
- 5 weeks ago - Tiziana Life Sciences doses last patient in intranasal foralumab trial - TheFly
- 5 weeks ago - Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial - GlobeNewsWire
- 7 weeks ago - Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares - TheFly
- 2 months ago - Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York - GlobeNewsWire